Denis Ouzan
About
In The Last Decade
Denis Ouzan
122 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 96
- Hepatology 2.1k
- Epidemiology 2.0k
- Infectious Diseases 305
- Rheumatology 166
- Surgery 82
Countries citing papers authored by Denis Ouzan
This map shows the geographic impact of Denis Ouzan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denis Ouzan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denis Ouzan more than expected).
Fields of papers citing papers by Denis Ouzan
This network shows the impact of papers produced by Denis Ouzan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denis Ouzan. The network helps show where Denis Ouzan may publish in the future.
Co-authorship network of co-authors of Denis Ouzan
This figure shows the co-authorship network connecting the top 25 collaborators of Denis Ouzan. A scholar is included among the top collaborators of Denis Ouzan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denis Ouzan. Denis Ouzan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | HCVerso2: a phase III study of faldaprevir plus deleobuvir and ribavirin for chronic HCV genotype 1b infection in treatment naïve patients including those ineligible for pegylated interferon | 1 |
| 4 | 79 | |
| 5 | 2 | |
| 6 | 0 | |
| 7 | 11 | |
| 8 | 1 | |
| 9 | 9 | |
| 10 | 148 | |
| 11 | 35 | |
| 12 | 5 | |
| 13 | 13 | |
| 14 | [Registry of liver biopsies from hepatitis C infected patients in the Alpes-Maritimes (France). Results from the first 2 years]. | 2 |
| 15 | Que devient le matériel usagé (aiguilles, flacons, seringues, stylos) après injection d'interféron à domicile? | 1 |
| 16 | 6 | |
| 17 | [Pretreatment with prednisolone enhances the effect of human lymphoblastoid interferon in chronic hepatitis B]. | 2 |
| 18 | 4 | |
| 19 | 18 | |
| 20 | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.